Investor Education Webinar - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Investor Education Webinar ##### Up next ###### [Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis](https://thailandbusinessnews.net/press-release/lynk-pharmaceuticals-announces-positive-phase-iii-topline-data-of-zemprocitinib-in-moderate-to-severe-atopic-dermatitis/) Published on 02 March 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/1920208/Telix_Main_Logo_Logo.jpg?p=medium600 "logo")**The Future of Prostate Imaging: What do physicians want?** MELBOURNE, Australia and INDIANAPOLIS, March 2, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") invites investors to join a webinar with key opinion leaders to discuss a physician’s perspective on innovations in PSMA-PET/CT imaging for prostate cancer. Speakers: - Rodney Hicks, MD, Professor of Medicine at the University of Melbourne and Monash University; Founder, Executive Chairman and Chief Medical Officer at the Melbourne Theranostic Innovation Centre (MTIC); - Paul Yonover, MD, FACS, Chief Data Officer and Director of Clinical Navigation at UroPartners, a division of The Specialty Alliance; Chief of Urology at Ascension Saint Joseph Hospital, Chicago; and - Darren Patti, PharmD, Telix Group Chief Operating Officer. The webinar will be moderated by David N. Cade, MD, Telix Group Chief Medical Officer. **The webinar will be held on:** **EST:** Wednesday March 4, 2026, 5:30 p.m. **AEDT:** Thursday March 5, 2026, 9:30 a.m. The event will run for approximately one hour. Participants can register for the webcast at the following link: **About Telix Pharmaceuticals Limited** Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX). Visit [www.telixpharma.com](http://www.telixpharma.com/) for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on [LinkedIn](https://www.linkedin.com/company/telixpharma/), [X](https://x.com/TelixPharma) and [Facebook](https://www.facebook.com/TelixPharma). **Telix Investor Relations (Global)** Ms. Kyahn Williamson SVP Investor Relations and Corporate Communications **Telix Investor Relations (Australia)** Ms. Charlene Jaw Associate Director Investor Relations **Telix Investor Relations (U.S.)** Ms. Annie Kasparian Director Investor Relations and Corporate Communications Legal Notices *Cautionary Statement Regarding Forward-Looking Statements.* *You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.* *The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.* *This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "believe", "outlook", "forecast" and "guidance", or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, including the planned NDA resubmission for TLX101-Px and the planned BLA resubmission for TLX250-Px, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.* *Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.* *©2026 Telix Pharmaceuticals Limited. All rights reserved.* [Source link ](http://www.prnasia.com/story/archive/4898624_AE98624_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/infosys-and-formula-e-launch-ai-powered-race-centre-taking-fan-experience-to-pole-position/) ## Infosys and Formula E Launch AI-Powered Race Centre, Taking Fan Experience to Pole Position New digital platform leverages Infosys Topaz to deliver real-time insights that will… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - March 20, 2026 [](https://thailandbusinessnews.net/press-release/spirit-advisors-client-picocela-inc-completes-its-nasdaq-ipo/) ## Spirit Advisors Client PicoCELA Inc completes its Nasdaq IPO TOKYO and NEW YORK, Jan. 20, 2025 /PRNewswire/ — Spirit Advisors LLC… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - January 20, 2025 [](https://thailandbusinessnews.net/press-release/sk-bioscience-board-approves-financing-plan-supported-by-korea-growth-fund/) ![SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund](https://i0.wp.com/mma.prnasia.com/media2/2990318/image1.jpg?resize=260%2C140&ssl=1 "SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund SK bioscience’s board approval follows the Financial Services Commission’s May 28 announcement… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 29, 2026 ##### Most Read - [![Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") [Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") - [![Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/MODERN_MEADOW_LOGO_BLACK_PNG_Logo.jpg?fit=597%2C138&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") [Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") - [![IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") [IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") - [![DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") [DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") - [![Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") [Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") - [![MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") [MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/dbs-gathers-global-leaders-at-inaugural-asia-future-forward-conference-as-ai-rewrites-the-world/) ## DBS Gathers Global Leaders At Inaugural Asia Future Forward Conference As AI Rewrites The World Shou Chew, Lip-Bu Tan, Hock Tan and Jenny Johnson among influential figures… [](https://thailandbusinessnews.net/press-release/midea-showcases-breakthrough-cooling-technologies-for-high-density-ai-data-centers-at-data-center-world-asia-2026/) ![Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026](https://i0.wp.com/mmx.prnasia.com/media/MS1999346/20260929231123EDT_image_1.jpg?resize=260%2C140&ssl=1 "Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026") ## Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026 SINGAPORE, Oct. 2, 2026 /PRNewswire/ — The Asia Data Centre World 2026… [](https://thailandbusinessnews.net/press-release/registration-opens-for-the-2026-eye-level-math-olympiad/) ![Registration Opens for the 2026 Eye Level Math Olympiad](https://i0.wp.com/mmx.prnasia.com/media/MS2000596/20261001022140EDT_image_1.jpg?resize=260%2C140&ssl=1 "Registration Opens for the 2026 Eye Level Math Olympiad") ## Registration Opens for the 2026 Eye Level Math Olympiad SEOUL, South Korea, Oct. 2, 2026 /PRNewswire/ — Eye Level has opened… [](https://thailandbusinessnews.net/press-release/curaleaf-international-secures-australian-first-with-tga-registered-liquid-medical-cannabis-inhalation-device-and-extends-availability-to-new-zealand/) ![Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand](https://i0.wp.com/mmx.prnasia.com/media/MS1612515/Curaleaf-International-Logo.jpg?resize=260%2C140&ssl=1 "Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand") ## Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand LONDON, Oct. 2, 2026 /PRNewswire/ — Curaleaf International, part of Curaleaf…